Red Book 2021-2024: Report of the Committee on Infectious Diseases | Agenda Bookshop Skip to content
Online orders placed from 19/12 onward will not arrive in time for Christmas.
Online orders placed from 19/12 onward will not arrive in time for Christmas.
Age Group_Uncategorized
Age Group_Uncategorized
automatic-update
B01=David W. Kimberlin
B19=Elizabeth Barnett
B19=Mark H. Sawyer
B19=Ruth Lynfield
Category1=Non-Fiction
Category=MBPC
Category=MJC
Category=MJCJ
Category=MJW
Category=MQCL
Category=MQCL3
COP=United States
Delivery_Delivery within 10-20 working days
Language_English
PA=Available
Price_€100 and above
PS=Active
softlaunch

Red Book 2021-2024: Report of the Committee on Infectious Diseases

★★★★★
★★★★★

English

Refer to the Red Book. That's been the watchword for generations of healthcare professionals seeking trustworthy guidance on pediatric infectious disease prevention, management, and control. Now the 32nd edition continues this tradition of excellence with the latest clinical guidance on manifestations, etiology, epidemiology, diagnosis and treatment of more than 200 childhood infectious diseases.

The 32nd edition provides evidence-based guidance on pediatric infections and vaccinations based on the recommendations of the committee as well as the combined expertise of the CDC, the FDA and hundreds of contributors.

Red Book is an indispensable reference for pediatricians and pediatric infectious disease specialists and is useful for family medicine and emergency medicine physicians, as well. Public health and school health professionals, medical residents, and students also will find it a high-yield source of pediatric infectious disease and vaccine information.

New in the 2021 Red Book:

  • All chapters were assessed for relevance in the dynamic environment that is the practice of medicine today, and every chapter has been modified.
  • Two chapters have been added to the 2021 edition: Pseudomonas aeruginosa Infections and a new System-Based Treatment table designed to aid in initial antibiotic selections by clinical conditions.
  • Standardized approaches to disease prevention through immunizations, antimicrobial prophylaxis, and infection-control practices have been updated throughout the Red Book
  • References to evidence-based policy recommendations have been updated throughout the Red Book.
  • Appropriate chapters throughout the Red Book have been updated to be consistent with 2021 AAP and CDC vaccine recommendations for immunization of health care personnel, and drug recommendations from 2021 Nelson's Pediatric Antimicrobial Therapy.
    • See more
    €126.48
    €138.99
    Save 9%
    Age Group_Uncategorizedautomatic-updateB01=David W. KimberlinB19=Elizabeth BarnettB19=Mark H. SawyerB19=Ruth LynfieldCategory1=Non-FictionCategory=MBPCCategory=MJCCategory=MJCJCategory=MJWCategory=MQCLCategory=MQCL3COP=United StatesDelivery_Delivery within 10-20 working daysLanguage_EnglishPA=AvailablePrice_€100 and abovePS=Activesoftlaunch
    Delivery/Collection within 10-20 working days
    Product Details
    • Weight: 1408g
    • Dimensions: 152 x 229mm
    • Publication Date: 30 May 2021
    • Publisher: American Academy of Pediatrics
    • Publication City/Country: United States
    • Language: English
    • ISBN13: 9781610025218

    About

    David W. Kimberlin MD FAAP is the Editor of the 2021 AAP Report of the Committee on Infectious Diseases (Red Book). He also was Editor of the 2015 and 2018 editions and was an Associate Editor of the 2012 and 2009 editions and served on the AAP Committee on Infectious Diseases from 2005- 2011. Dr Kimberlin is the Sergio Stagno MD. Endowed Chair in Infectious Diseases Professor and Co-Division Director Vice Chair for Clinical and Translational Research. His clinical and research interests include pediatric infectious diseases antiviral therapeutics in rare diseases with a large unmet medical need including neonatal herpes simplex virus (HSV) infections congenital cytomegalovirus (CMV) disease congenital Zika infection neonatal and infantile influenza infection and neonatal enteroviral sepsis syndrome.Elizabeth D. Barnett MD FAAP is an Associate Editor of the 2021 Red Book and was a member on the Committee on Infectious Diseases from 2014 - 2020. Dr Elizabeth Barnett is Professor of Pediatrics at Boston University School of Medicine and Chief Section of Pediatric Infectious Diseases in the Department of Pediatrics at Boston Medical Center.  She leads the Refugee Health Assessment Program and the Pediatric Travel Clinic. Her clinical and research interests include vaccines and vaccine safety refugee and immigrant medicine travel medicine and general pediatric infectious diseases.     Ruth Lynfield MD FAAP is an Associate Editor of the 2021 Red Book and has been a member of the the Committee on Infectious Diseases since 2015. Dr Lynfield is the State Epidemiologist and Medical Director at the Minnesota Department of Health. She leads Minnesota's component of CDC's Emerging Infections Program Active Bacterial Core Surveillance System influenza projects and healthcare-associated infections projects. She is also Adjunct Professor of Medicine and Epidemiology and Community Health at the University of Minnesota. Her clinical and research interests include pediatric infectious diseases antimicrobial resistance and antimicrobial stewardship emerging infections prevention and control of infectious diseases and outbreak response.Mark Sawyer MD FAAP is an Associate Editor of the 2021 Red Book and served on the Committee on Infectious Diseases from 2013- 2019. Dr Sawyer is an infectious disease specialist at Rady Children's Hospital and a professor of clinical pediatrics at UC San Diego. Additionally Dr. Sawyer is vice chair for education in the UC San Diego Department of Pediatrics and the program director for the UC San Diego/Rady Children's Pediatric Residency Program and the medical director of the UC San Diego  Immunization Partnership. His clinical and research interests include pediatric infectious diseases medical education training and working with public health on the delivery of vaccines and national vaccine policy.

    Customer Reviews

    Be the first to write a review
    0%
    (0)
    0%
    (0)
    0%
    (0)
    0%
    (0)
    0%
    (0)
    We use cookies to ensure that we give you the best experience on our website. If you continue we'll assume that you are understand this. Learn more
    Accept